What is the reclassification of cannabis in the US?

A local expert explains the significance of the rescheduling

As posted on CBD Library, a Japanese CBD Shop Search

December 19, 2025 Using Google Translate on the page
Thomas Andersen, BTA Cannabis CPA Tax

On December 18, 2025, the news that President Trump had signed an executive order to reclassify (reschedule) cannabis as a “less dangerous drug” was widely reported.

“Is it finally legalized in the United States?” Headlines and expectations like this are spreading around the world.

But the bottom line is that rescheduling does not mean “legalization.”

Still, this move marks a historic step in American cannabis policy, a turning point that will have profound implications for healthcare, industry, finance, taxation, and even patients’ lives.

In Japan, the law was revised for the first time in 75 years in December 2024, but it cannot be said that there is sufficient understanding of what is happening overseas and what reality awaits us in the future.

That is why we felt it was necessary to convey this news accurately, as material for thinking about Japan’s future.

This time we bring you someone with over 20 years of industry experience.

This article is a contribution by Thomas Andersen, founder of BTA Cannabis CPA Tax, a tax and accounting firm specializing in the American cannabis and hemp industry, and editor-in-chief of the specialized media outlet WeedingTheNews…

Read the full article here.

Share This Article. Choose Your Platform!